The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations

The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations

10.4088/JCP.11m07043

Saved in:

Bibliographic Details
Main Authors:	Sung, S.C., Haley, C.L., Wisniewski, S.R., Fava, M., Nierenberg, A.A., Warden, D., Morris, D.W., Kurian, B.T., Trivedi, M.H., Rush, A.J.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110642
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: A CO-MED report
by: Bobo, W.V., et al.
Published: (2014)

Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: A suicide assessment methodology study report
by: Warden, D., et al.
Published: (2014)

Adherence to antidepressant combinations and monotherapy for major depressive disorder: A CO-MED report of measurement-based care
by: Warden, D., et al.
Published: (2014)

Bayesian meta-analyses of the tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants for treating patients with depression
by: Pang, C.S., et al.
Published: (2014)

Relationship between obesity and depression: Characteristics and treatment outcomes with antidepressant medication
by: Toups, M.S.P., et al.
Published: (2014)

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication
by: McClintock, S.M., et al.
Published: (2014)

The effectiveness of antidepressant monotherapy in a naturalistic outpatient setting
by: Lee, T.-S., et al.
Published: (2014)

Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: An exploratory report from the combining medications to enhance depression outcomes study
by: Zisook, S., et al.
Published: (2014)

Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED Trial Report
by: Sung, S.C., et al.
Published: (2014)

Concise associated symptoms tracking scale: A brief self-report and clinician rating of symptoms associated with suicidality
by: Trivedi, M.H., et al.
Published: (2014)

The Effect of Serotonin-Norepinephrine Reuptake Inhibitor Milnacipran on Anxiety-like Behaviors in Diabetic Mice
by: Tuhfatul Ulya, -, et al.
Published: (2021)

Selective serotonin reuptake inhibitors and oral bleeding complications after invasive dental treatment
by: Napeñas, J.J., et al.
Published: (2013)

Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients
by: Trivedi, M.H., et al.
Published: (2014)

Do menopausal status and use of hormone therapy affect antidepressant treatment response? Findings from the sequenced treatment alternatives to relieve depression (STAR*D) study
by: Kornstein, S.G., et al.
Published: (2014)

STAR*D: Revising conventional wisdom
by: Rush, J.A., et al.
Published: (2014)

Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Stroke Rehabilitation: A Prospective Observational Pilot Cohort Study
by: Yeo, S.-H., et al.
Published: (2021)

Selective Serotonin Reuptake Inhibitor Fluvoxamine Ameliorates Stress-and NSAID-Induced Peptic Ucler Possibly by involving Hsp70
by: Junaidi Khotib, NIDN. 0022107001, et al.
Published: (2018)

Combinatorial support vector machines approach for virtual screening of selective multi-target serotonin reuptake inhibitors from large compound libraries
by: Shi, Z., et al.
Published: (2014)

The Antidepressant Effect of Fluoxetine and Mozart K448 Combination Therapy on Hippocampal Serotonin and BDNF Levels
by: Lisa Pangemanan, -, et al.
Published: (2023)

Concise health risk tracking scale: A brief self-report and clinician rating of suicidal risk
by: Trivedi, M.H., et al.
Published: (2014)

What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression
by: Gaynes, B.N., et al.
Published: (2014)

Are they being used safely? A retrospective cross-sectional tertiary health care survey of selective serotonin reuptake inhibitors prescribing practice in Singapore
by: Xie, F., et al.
Published: (2014)

Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: An exploratory analysis of a single-blind randomized trial
by: Davis, L.L., et al.
Published: (2014)

Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and long-term outcomes of a single-blind randomized study
by: Rush, A.J., et al.
Published: (2014)

Prenatal selective serotonin reuptake inhibitor (SSRI) exposure induces working memory and social recognition deficits by disrupting inhibitory synaptic networks in male mice
by: Yu, Weonjin, et al.
Published: (2019)

Depression treatment in patients with general medical conditions: Results from the CO-MED trial
by: Morris, D.W., et al.
Published: (2014)

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: Results of the NIMH star*D trial
by: Friedman, E.S., et al.
Published: (2014)

Association of polymorphisms in genes regulating the corticotropin- releasing factor system with antidepressant treatment response
by: Binder, E.B., et al.
Published: (2014)

Diurnal mood variation in outpatients with major depressive disorder
by: Morris, D.W., et al.
Published: (2014)

Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: A CO-MED report
by: Chan, H.N., et al.
Published: (2014)

Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report
by: Rush, A.J., et al.
Published: (2014)

A practical approach to the early identification of antidepressant medication non-responders
by: Li, J., et al.
Published: (2014)

Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research?
by: Joseph Goldberg, et al.
Published: (2018)

Do atypical features affect outcome in depressed outpatients treated with citalopram?
by: Stewart, J.W., et al.
Published: (2014)

What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?
by: Gollan, J.K., et al.
Published: (2014)

Income and attrition in the treatment of depression: A STAR*D report
by: Warden, D., et al.
Published: (2014)

To each their own
by: Teo, Cai Yun
Published: (2016)

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement
by: Seetal Dodd, et al.
Published: (2018)

DETERMINATION OF ANTIDEPRESSANT ACTIVITY OF DARK CHOCOLATE
by: A P Nitamakwuavan, Puvaneswari

Family history of depression and therapeutic outcome: Findings from STAR*D
by: Husain, M.M., et al.
Published: (2014)